Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemabate for Fibroid Resection Pilot
NCT05518812Phase 1Completed
- Sponsor
- Northwestern University
- Start
- Jul 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of carboprost in Uterine Fibroids (UF), sponsored by Northwestern University. Primary endpoint: Does instillation of low-dose carboprost facilitate complete resection of FIGO II fibroids during hysteroscopic resection? Started Jul 2022; status: completed.
02
Drugs
carboprost
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT05518812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05518812.